来自Cistanche deserticola的总基醇通过调节胆酸代谢来减轻功能性便秘
Hongmei Yin1, Xia Gao1, Hao Yang2
1Nanjing University of Chinese Medicine, Nanjing, 210023, China; National Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Jiangsu Kanion Pharmaceutical Co., Ltd. Lianyungang, 222001, China; Jiangsu Kanion Modern Chinese Medicine Institute, Nanjing, 211100, China.
锡斯坦奇全提取物 (CTAE) 通过调节胆酸代谢和肠肝循环,有效治疗大鼠的功能性便秘 (FC). 这种传统中医药在开发新的FC疗法方面表现有前途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 代谢学 代谢学 代谢学
背景情况:
- 功能性便秘 (FC) 显著影响患者的福祉,治疗选择有限.
- 传统中医药中的Cistanche deserticola含有cistanche总阿尔迪托尔提取物 (CTAE),这是FC的潜在治疗剂.
研究的目的:
- 为了研究CTAE在FC的老鼠模型中的疗效和机制.
- 采用多学科的方法,包括代谢学和西式涂抹,以获得机械的见解.
主要方法:
- 开发了一种使用二氧酸盐片的FC大鼠模型.
- 评估了CTAE对肠道运输,神经递质,炎症和卡哈尔 (ICC) 间歇细胞的影响.
- 采用非向的代谢学,胆酸代谢学和西部抹杀来阐明机制.
主要成果:
- 在FC大鼠中,CTAE改善了肠道运输,调节了神经递质,并减少了炎症.
- 代谢分析显示,CTAE可以缓解FC诱导的代谢障碍,特别是在胆酸生物合成和肠肝循环中.
- 西方涂抹证实CTAE通过增加CYP8B1,FGF15,TGR5和FXR的表达来调节胆酸合成.
结论:
- 在功能性便秘方面,CTAE具有显著的治疗效果.
- 主要机制涉及胆酸合成和肠肝循环的调节.
- CTAE显示了开发用于治疗FC的新药的潜力.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Ulcerative Colitis in IBD


